Wernli, Martin

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 7.

Journal Article

Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Tim H; Fabarius, Alice; Haferlach, Claudia; Schlegelberger, Brigitte; Balleisen, Leopold; Goebeler, Maria-Elisabeth; Hänel, Mathias; Ho, Anthony; ... (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica - the hematology journal, 104(5), pp. 955-962. Ferrata-Storti Foundation 10.3324/haematol.2018.206797

Saussele, Susanne; Krauss, Marie-Paloma; Hehlmann, Rüdiger; Lauseker, Michael; Proetel, Ulrike; Kalmanti, Lida; Hanfstein, Benjamin; Fabarius, Alice; Kraemer, Doris; Berdel, Wolfgang E; Bentz, Martin; Staib, Peter; de Wit, Maike; Wernli, Martin; Zettl, Florian; Hebart, Holger F; Hahn, Markus; Heymanns, Jochen; Schmidt-Wolf, Ingo; Schmitz, Norbert; ... (2015). Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV. Blood, 126(1), pp. 42-49. American Society of Hematology 10.1182/blood-2015-01-617993

Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C; Hanfstein, Benjamin; Krause, Stefan W; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; ... (2014). Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV. Annals of hematology, 93(7), pp. 1167-1176. Springer 10.1007/s00277-014-2041-0

Schwappach, David L B; Wernli, Martin (2010). Predictors of chemotherapy patients' intentions to engage in medical error prevention. Oncologist, 15(8), pp. 903-912. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2010-0117

Schwappach, David L. B.; Hochreutener, Marc-Anton; Wernli, Martin (2010). Oncology nurses' perceptions about involving patients in the prevention of chemotherapy administration errors. Oncology nursing forum, 37(2), E84-E91. Pittsburgh, Pa.: Oncology Nursing Society 10.1188/10.ONF.E84-E91

Schwappach, David L B; Wernli, Martin (2010). Chemotherapy patients' perceptions of drug administration safety. Journal of clinical oncology, 28(17), pp. 2896-2901. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2009.27.6626

Schwappach, David L B; Wernli, Martin (2010). Am I (un)safe here? Chemotherapy patients' perspectives towards engaging in their safety. Quality & safety in health care, 19(5), e9. London: BMJ Publishing Group 10.1136/qshc.2009.033118

This list was generated on Sat May 30 10:17:35 2020 CEST.
Provide Feedback